A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

C Smit; RE Wasmann; SC Goulooze; EJ Hazebroek; EPA Dongen; DMT Burgers; Johan Mouton; RJ Bruggemann; Catherijne Knibbe

doi:10.1007/s40262-019-00762-4

A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

C Smit
, RE Wasmann
, SC Goulooze
, EJ Hazebroek
, EPA Dongen
, DMT Burgers
, Johan Mouton
, RJ Bruggemann
, Catherijne Knibbe

Medical Microbiology & Infectious Diseases

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

21 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1333-1343
Number of pages	11
Journal	Clinical Pharmacokinetics
Volume	58
Issue number	10
DOIs	https://doi.org/10.1007/s40262-019-00762-4
Publication status	Published - 2019

Research programs

EMC MM-04-28-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40262-019-00762-4

Repub_120456_O-A.pdfFinal published version, 1.3 MB

Cite this

Smit, C., Wasmann, RE., Goulooze, SC., Hazebroek, EJ., Dongen, EPA., Burgers, DMT., Mouton, J., Bruggemann, RJ., & Knibbe, C. (2019). A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients. Clinical Pharmacokinetics, 58(10), 1333-1343. https://doi.org/10.1007/s40262-019-00762-4

@article{ea6896f787554638b3e615773b192193,

title = "A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients",

author = "C Smit and RE Wasmann and SC Goulooze and EJ Hazebroek and EPA Dongen and DMT Burgers and Johan Mouton and RJ Bruggemann and Catherijne Knibbe",

year = "2019",

doi = "10.1007/s40262-019-00762-4",

language = "Undefined/Unknown",

volume = "58",

pages = "1333--1343",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "10",

}

Smit, C, Wasmann, RE, Goulooze, SC, Hazebroek, EJ, Dongen, EPA, Burgers, DMT, Mouton, J, Bruggemann, RJ & Knibbe, C 2019, 'A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients', Clinical Pharmacokinetics, vol. 58, no. 10, pp. 1333-1343. https://doi.org/10.1007/s40262-019-00762-4

TY - JOUR

T1 - A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

AU - Smit, C

AU - Wasmann, RE

AU - Goulooze, SC

AU - Hazebroek, EJ

AU - Dongen, EPA

AU - Burgers, DMT

AU - Mouton, Johan

AU - Bruggemann, RJ

AU - Knibbe, Catherijne

PY - 2019

Y1 - 2019

U2 - 10.1007/s40262-019-00762-4

DO - 10.1007/s40262-019-00762-4

M3 - Article

C2 - 31016671

SN - 0312-5963

VL - 58

SP - 1333

EP - 1343

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 10

ER -